Pro Healthcare Briefing: Politics and Prices: What's Next for Drug Costs?
Join POLITICO's Pro Health Care team for a conversation on the future of prescription drug costs. How has the emergence of high-profile extreme cases, including EpiPen and Daraprim, shaped the policy landscape? How will the mounting concerns of health care spending affect the debate about drug costs in 2017 and beyond?







